Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction

Pancreatic ductal adenocarcinoma (PDAC) has the poorest prognosis of all malignancies and is largely resistant to standard therapy. Novel treatments against PDAC are desperately needed. Anti-Gal is the most abundant natural antibody in humans, comprising about 1% of immunoglobulins and is also natur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Tanemura, Masahiro, Miyoshi, Eiji, Nagano, Hiroaki, Eguchi, Hidetoshi, Matsunami, Katsuyoshi, Taniyama, Kiyomi, Hatanaka, Nobutaka, Akamatsu, Hiroki, Mori, Masaki, Doki, Yuichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2015
Assuntos:
Topic Highlight
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616216/
https://ncbi.nlm.nih.gov/pubmed/26523105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i40.11396
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados